Skip to main content
Premium Trial:

Request an Annual Quote

Sygnis TruePrime WGA Kit

Sygnis has launched the TruePrime WGA kit for whole-genome amplification of entire genomes from various sample types.

The TruePrime technology is based on multiple displacement amplification (MDA) of DNA or RNA species from a variety of samples. TruePrime combines Sygnis' recently discovered DNA primase TthPrimPol with its Phi29 polymerase, and does not require the use of any synthetic random primers. The new kit eliminates common artifacts linked to the use of oligonucleotides, reduces amplification bias, is insensitive to external DNA contaminations, and has a high reproducibility, the company said. These features make it attractive for researchers who are working with limited sample volumes but do not need to obtain DNA from individual cells, Sygnis added.

The TruePrime WGA kit is available globally through distributors as well as through Sygnis' TruePrime online shop. It is available in 25- or 100-reaction formats.

Sygnis also previously launched a TruePrime kit for amplification of DNA from single cells.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.